ORALLY DIS INTEGRATING TAB LETS :
The centre for drug evaluation and Research defines orally disintegrating tablets as a dosage form -"A solid dosage form wh ich disintegrates rapidly within a matter of seconds when placed under the tongue". The disintegrating time for orally disintegrating tablet varies fro m seconds to minutes, depends upon the size of tablet and formulation. European pharmacopeia defined orally disintegrating tablets as-"Uncovered tablet which disperse before ingestion in the buccal cavity". Different technological techniques such as freeze drying or moulding or direct compression etc.are used to prepare the formulat ion of this type in the pharmaceutical market 2 
DES IRED CHARACTERIS TICS OF ODT:
1] Bioavailability 2] Rap id drug therapy intervention is possible 4. 3] Sufficient mechanical strength 4] A llo w h igh drug loading 9. 5] Rap id onset of theuraptic action 6] Good compatib ility with develop ment technology 7. 7] Leaves no residue in mouth after oral ad ministration 8] Stability 9] Conventional packaging and processing equipments allo ws the manufacturing of tablets at low cost 4, 9. 10] Be co mpatib le with taste masking and other excipients
ADVANTAGES OF ODT:
1] It can be ad ministered to the patient who cannot swallow conventional dosage form such as bedridden patients, elderly and patient effected by renal failure and thus improves patient compliance 6. 2] It is suitable for bedridden, disabled, traveler and busy persons who does not contain water every time 5. 3] Good mouth feel property helps to mask the bitterness of medicines.
4] Rap id drug therapy intervention.
5] It provides rapid absorption of drugs and increased bioavailability. 
TRADITIONAL TAS TE MAS KING TECHNOLOGIES IN

4] Taste masking using Lipophillic Vehicles
FORMULATION ASPECTS IN DEVELOPING ODT:
ODT's are formulated by several processes, which differ in their methodologies and vary in various properties such as: In order to swallow ODTs to disintegrate in the oral cavity, they are either made of porous or soft molded matrices, which makes tablet friable and difficult to handle and hence requires peel-off blister packing which increases its cost 11 , 12. 
2] Pal atability:
Since most drugs are unpalatable, orally disintegrating drug delivery system contains medicament in taste masked form 13. It dissolves in patient oral cavity, thus release the active ingredient wh ich co mes in contact with the taste buds 5 .
3] Aqueous solubility:
Water soluble drugs pose various formulat ion challenges results in freezing point depression and formation of glassy solids that may collapse upon drying. Such collapse can be prevented by using various matrix fo rming excipients like mannitol 11, 15. 
4] Amount of drug:
The application for technologies used for ODTs is limited by the amount of drug into each unit dose 14 .The drug dose must be lower than 400mg for insoluble drugs and 60mg for soluble drugs 12 .
5] Size of tablet:
The easiest size of tablet to swallow is 7-8mm while the easiest size to handle is 8mm.Therefore, tablet size that is easy to handle and easy to take is difficult to achieve.
6] Hygroscopicity:
Many orally disintegrating dosage forms are hygroscopic in nature 12, 5 . Hence they need protection from hu mid ity. 
MECHANIS M OF ODTs
1] Freeze drying:
It is a process in which water is sublimated fro m the product after freezing. In this heat sensitive drugs and biological are dried at low temperature that allows removal of water by sublimation 25 .
2] Sublimati on:
In these, inert solid ingredient that volatilized readily was added to other tablet ingredient and mixtu re is compressed into tablets. The volatile material was then removed by the process of sublimation 19, 37 .
3] Spray-drying : It produces very fine and highly porous powder. Tablets prepared from spray drying disintegrate within 20 sec when immersed in an aqueous mediu m 27 .
4] Mol ding :
In these, water soluble ingredients are used to prepare molded tablets so that tablet dissolves rapidly. Molded tablets are very less compact then compressed tablets and exh ibit porous structure for rapid d issolution.
5] Mass-extrusion:
It involves softening the active blends using the solvent mixture of water soluble PEG. The granules of bitter tasting drugs are coat by dried cylinders and hence masking their b itter taste 26 , 28 .
6] Disintegrates addi tion:
Because of its easy implementation and cost effectiveness, it is a popular technique for formulating ODT's.The basic principle involved is addition of superdisintegrants in optimu m conc.
7] Direct compression:
It is the easiest way of manufacturing tablets. It consists of a limit ing number of processing steps, conventional equipments and commonly available excipients. Also it requires few unit operations as compared to wet granulat ion 7, 20 . 
4] Durasol v Technology:
It is a patented technology of "CIMA" labs. It consists of druf, fillers and lubricant. It requires low amount of active ingredient 23 .
5] Zydis Technol ogy:
It involves quick dissolution, increased bioavailability and self-preserving. It involves softening the active blends using the mixture of methanol and polyethylene glycol.
6] Orasol v Technol ogy:
It is patented technology of "CIMA" labs. It involves quick dissolution and taste masking of active ingredient 29, 37 . 10] Stability studies. 
EVALUATION OF ODT's
B UCCAL PATCHES:
Buccal route of drug delivery provides direct access to the systemic circulation through the jugular vein by passing the first pass hepatic metabolism and hence increases its bioavailability 24 .The buccal patches can solve the problem of short residence time of oral gel on mucosa. However buccal patches can offer greater advantages and comfort then other devices such as low enzy mat ic activ ity, greater accessibility, easy withdrawal, painless admin istration, and © 2011, JDDT. All Rights Reserved ISSN: 2250-1177 CODEN: JDDTAO facility to induce permeation enhancer or ph modifier in the formulat ion, versatility in designing as unidirectional or mult idirect ional release system for local or systematic action 19 .
ADVANTAGES OF B UCCAL PATCHES :
1] It is well known for their good accessibility to the memb rane that lines the oral cavity, which makes application co mfort 24 .
2] The drug gains direct entry into the systemic circulat ion in buccal ad min istration, thereby passing the first pass effect. In these, rate of drug absorption is not affected by gastric emptying rate 22 .
3] In these, drugs are absorbed from the oral cavity and transported through the deep facial vein, internal jugular vein, braciocephalic vein into the systemic circulation.
4] The buccal drug delivery system easily ad ministered into the buccal cavity and hence exh ibit better patient compliance 19 . 
COMPOS ITION OF B UCCAL PATCHES
FACTORS AFFECTING B UCCAL ABSORPTION:
There are two factors which affect buccal absorption-
1] Membrane factors:
It involves surface area for absorption, mucus layer of salivary pellicle, intercellu lar lip ids of epitheliu m and degree of keratinizat ion 36 .
2] Environmental factors:
These include saliva and salivary glands. The thin film of saliva coats throughout the buccal mucosa and called the salivary films. The thickness of salivary film is 0.07 to 0.10mm. The minor salivary glands are located in the epithelial reg ion of buccal mucosa and constantly secrets mucus on surface of buccal mucosa 24 . 35 :
MET HOD OF PREPARATION OF B UCCAL PATCHES
There are two methods available fo r preparation of buccal patches-
1] Direct milling:
In this method, drugs and excipients are mixed by direct milling without the need of water. Then the resultant material is rolled on a release liner. The backing material is then laminated. In these method patches are made without solvent.
2] Sol vent casting:
In these, all patch excipient and drug are co-dispersed in an organic solvent and then coated on to a sheet of release liner. After solvent evaporation a backing material is laminated onto the sheets of coated release liner until the desired thickness is achieved. 22, 30, 35 :
EVALUATION OF B UCCAL PATCHES
1] Thickness measurements:
The thickness of each film is measured by using electronic digital micro meter at five d ifferent locations.
2] Thermal anal ysis study:
It is done by using Differential scanning calorimetry.
3] Surface PH:
It is measured by means of a ph paper placed on the surface of a swollen patch. Buccal patches are swell when placed on the surface of agar plate.
4] Morphol ogical characterization:
It is done by using scanning electron microscope.
5] Swelling study:
As we know buccal patches are swell when placed on the surface of agar plate. After 1 hour plates are removed from the gel plates and excess water is removed using filter paper.
6] Water absorption capacity test:
Circular patches are prepared in simulated saliva are allo wed to swell on agar plate and kept in an incubator. At various time interval samples are weighed and left to dry in a dessicator over anhydrous calciu m chloride at room temperature and final constant weight is recorded.
7] In vitro drug release:
To study the drug release from mu lt ilayered and bilayered patches (USP) XXX111-B rotating paddle method is used. Phosphate buffer ph 6.8 is used as a dissolution med ia. The in vitro buccal permeation through the buccal mucosa is performed using Fran z type glass diffusion cell.
8] Permeation study of buccal patch:
Phosphate buffer ph 6.8 is filled in receptor compart ment and hydrodynamics is maintained by stirring with a magnetic bead. Samples are withdrawn at predetermined time intervals and analyzed.
9] Measurement of mechanical properties:
It includes tensile strength and elongation at break is evaluated using a tensile tester. Clamps are designed to secure the patch without crushing it during the test, the lower clamp held stationary and strips are pulled apart by the upper clamp. When the tip breaks the force and elongation of film is noted.
10] Stability study in human sali va:
The human saliva is collected fro m humans and stability study of bilayered and mult ilayered patches is performed © 2011, JDDT. All Rights Reserved ISSN: 2250-1177 CODEN: JDDTAO in human saliva. Buccal patches are placed in separated petridish containing 5ml of human saliva and placed in an oven. At regular time interval, dose formulat ion with better bioavailability is needed 19 .
ORALLY DIS INTEGRATING FILMS:
Orally disintegrating films is new drug delivery system for the oral delivery of drugs. Because of convenience and ease of use over other dosage form, orally disintegrating films have been introduced in the market 32 .Orally disintegrating films disintegrate within few seconds when placed on the tongue without the need of water. It was developed on the basis of transdermal patch technology. Recently oral films containing breath fresheners, API and vitamin supplements 31 . 
FEATUR ES OF ORALLY DIS INTEGRATING
7] Flavoring agents'
MET HODS OF PREPARATION OF ODF's:
There are various methods for preparation of ODF's which are enlisted below- 39 :
1] Sol vent casting method
In this method all water soluble excipients are dissolved in water and after then water soluble polymers and drug are added to form a ho mogeneous mixture at high shear processor. Finally solution is poured into the Petri plate for drying. In this method, solvent evaporates at high temperature.
2] Semisolid casting method:
In these method water soluble polymers and acid insoluble polymers are added which is prepared by the sodium hydroxide and ammoniu m hydro xide. At last, sufficient amount of plasticizer is also added to form a gel. Cellulose acetate phthalate and cellulose acetate butyrate are acid insoluble polymers which are used to prepare films. The film thickness is 0.015 to0.05 inches 40 .
3] Solid dispersion extrusion:
In this method solid dispersion is prepared and immiscible components are extruded and finally mixed with the drug. Finally with the help of dies solid dispersion are shaped in to films 34 .
4] Rolling method:
In this method, a drug and polymer suspension is prepared containing water or alcohol as solvent and subjected to the roller 41 .The suspension is then add on drum for evaporating the solvent and cutted into desired size and shapes 33 .
5] Hot melt extrusion:
In these method, drug is mixed with carrier in the solid form and and dried granular material is put into the extruder 42 .The screw speed should be 15rpm.In the extruder solid for carrier and drug is melt and placed in to dies and cutted into desired size and shapes 41 .
6] Freeze dried wafer:
In this method, dehydration of water occurs 41 . It reduces pressure from surrounding and allows the water in material to sublime directly .It is also called as lyophilisation method.
DIFFER ENT TECHNOLOGY US ED IN ODF's:
Technology used in formu lating ODF's are enlisted below- 
EVALUATING PARAMET ERS OF ODF's:
Various evaluating parameters of ODF's are-
1] Thickness 42 :
It can be measured by micro meter screw guage or vern ier calipers. For content uniformity and uniform film thickness, it can be checked at five different points by calibrated dig ital micro meter.
2] Mechanical properties:
a) Tensile strength-It is point at which film is break 32 Tensile strength = Load at failure× 100÷ Film thickness× Film width b) Percent elongation: It is calculated by the following formulae % elongation= Increase in length×100/Orig inal length
3] Fol di ng endurance:
Folding endurance value is determined by the number of times the film is folded without breaking.
4] Tear resistance:
Tear resistance value is the maximu m force or stress required to tear the specimen [43, 45] . It is expressed in Newton's or Pound-Force.
5] Surface ph of film:
It can be measured by placing the film on the surface of1.5%w/v agar gel by placing ph paper on film.
6] In vitro disintegration ti me:
In this method, films are placed in the mouth of volunteer and check the time to disintegrate the film 44 .
7] Contact angle:
It is measured by goniometer.In these method distilled water drop placed on dry film and picture is taken within 10 sec for angle determination 32 .
8] In vitro dissolution test:
It is performed in USPX111 type 11 apparatus in 0.1N HCL and 6.8 phosphate buffer. The samp les withdrawn at various time intervals and analyzed spectrophotometrically 42 .
9] Drug content and drug uni formity:
It is determined by estimating the API content in individual film 46 . It is also determined by specification in different pharmacopeia.
10] Trans parency:
It is determined using a simple UV spectrophotometer 46 .In these film samples are cut into rectangles and kept on internal side of spectrophotometer cell.
11] Taste evaluation:
It is going with panel of volunteers and the test sensors analyzed the sweetness level of taste masking agents.
12] Packaging:
The most commonly used packaging format is alu minu m pouch. Rapid card is used for packaging of Rapid films which is patented and proprietary packaging system of APR-Labtech 41, 44 . 
2] Water soluble g ums-
These contain high intensity sweeteners, Bulk sweeteners, Flavouring agents, Softners, Emu lsifiers, Colours and antioxidants. In this method, components of gums, sweeteners, softeners, active ingredients and excipient are added in a kettle mixer. This is then passing through a series of rollers. In these processes, a light coating of finely powdered sugar is added to the gum. At last, gum is cutted into desired shape and size.
2] Cooling, Grindi ng and Tabletting Method 48 :
This method is mainly used to lower the moisture content and reduces the problems mentioned in conventional method.
To achieve desired properties of chewing gum and to facilitate cooling, grinding certain additives are added to the chewing gum co mposition such asa) Us e of grinding agent. b) Use of Anticaking agent.
For Tabletting a Fluidized Bed Reactor can be used. In these method after the removal of coolant fro m the powder, it can be mixed with other ingredients such as binders, lubricants, sweeteners, colouring agent etc.in a suitable blender such as high shear mixture 48 . 51 :
3] Use of Direct Compression Chewing Gum Exci pients
This method can be used to overcome the limitations of melting and freezing method. In these methods, chewing gum can be manufactured under CGMP conditions and complies with Food Chemical Codex and FDA specifications. So they can be considered as (GRA S) "Generally Regarded as Safe" 47 .
APPLICATIONS OF CHEWING GUMS:
1] It is used to inhibit plaque growth.
2] It is used to mask the bitter taste of chlorhexidine 49 .
3] It is used to cure and prevent oral disease.
4]
It is used to provide a prolonged local effect 52 . 47 . 55 :
ORAL WAFERS
Oral wafers are also called or dispersible strips. These are thin films of 2-8cm square area and20-500µm thickness. It contains ≤50 mg of API.Wafers are administered on the tongue and dissolves in the mouth without intake of water within a few seconds. Now a days, few OTC products are available for preschool childrens.The products contains many excipients such as film forming agents derived from starch and cellulose,flavours,colouring agents, sweeteners and traces of class 3 residual solvents. The residual solvents act processing aids.
Oral wafers are usually provided as unit dose in child proof pouches. Recently, the first prescription-only oral wafer is Setofilm® approved in Europe for use in children's fro m 6 months onward by Applied Pharma Research and Labtec and MonoSol Rx.
SPECIAL FORMULATIONS-LOLLIPOPS AND GUMMY B EARS:
Special oral fo rmulat ions are lollipops and Gu mmy bears. Lo llipops are for children's above 3 years and gummy bears are for ch ild ren's above 3 years. These are sweet in taste. Due to its sweet taste they ate attractive to children's and parents can easily administered drug to their children's.
Lo llipops are formu late depend upon the individual taste. It is trendy in US co mpounding pharmacies 55 .However it should be labeled that these "special" formu lation are not "sweet" and kept out fro m reach of children's.
CONCLUS ION:
The area of formulating orally disintegrating dosage forms is aims at increasing the patient compliance and decreasing the disintegration time. It also aims of masking the objectionable taste of active ingredients. As compared to other complicated processes such as freeze drying etc., formulat ion of orally disintegrating dosage form is easy and overall cost of manufacturing is low. The potential of orally disintegrating dosage form to disintegrate in the oral cavity within seconds, fast onset of action, increasing patient compliance and taste masking of active ingredient makes it an attractive drug delivery form. Ho wever ,an addition of active ingredient in dosage form like orally disintegrating tablets, orally disintegrating films, oral wafers, buccal patches and chewing gums are excepted to provide a highly acceptable means of delivering drug to geriatric and pediatric patients.So.in forth coming years oral drug delivery becomes a much popular drug delivery.
